Great Point Partners’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
Other funds holding GYRE
BBA
Great Point Partners's GYRE Position: Q3 2013 in Review
Great Point Partners sold out of Gyre Therapeutics (GYRE) in Q3 2013, closing a stake of 233 shares — an estimated $1.57M sold.
Great Point Partners first reported a position in GYRE in Q2 2013 and held it in 1 quarter. The position peaked at $1.57M in Q2 2013. 73 funds tracked by Wall St. Rank hold GYRE as of Q3 2013.
- Great Point Partners reported no remaining Gyre Therapeutics position as of Q3 2013 after selling out during the quarter.
- Great Point Partners sold 233 Gyre Therapeutics shares in Q3 2013, an estimated $1.57M.
- Great Point Partners first reported a position in Gyre Therapeutics in Q2 2013 and held it in 1 quarter.
- Great Point Partners's Gyre Therapeutics position peaked at $1.57M in Q2 2013.
- 73 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2013.
Based on Great Point Partners's 13F filing for Q3 2013, filed 14 Nov 2013.